VHI FY2025 SEC EDGAR DEF 14A #74 of 168 in industry

Valhi Inc /de/ CEO pay ratio

The CEO earned $3.7M in FY2025 against median worker pay of $77,066 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-01
Industry
Chemicals & Pharmaceuticals
Industry rank
#74/168

Data updated August 2026

Subscribe to Valhi Inc /de/ CEO pay filing updates (RSS)

CEO-to-worker pay ratio
48:1
Below Average (Scale: 0–1000:1)
CEO pay
$3.7M
Median worker
$77,066

Answer first

Valhi Inc /de/'s FY2025 CEO total of $3.7M ranks #1028 of 1,423 complete filings; its 48:1 pay ratio ranks #989. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $77,066. Industry placement uses the FY2025 SIC-28 peer cohort (# 74 of 168, 57th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1028
$3.7M of 1,423 FY2025
Ratio rank
#989
48:1 of 1,423
Industry pct
57th
above the industry median pay ratio

How Valhi Inc /de/ ranks nationally

Valhi Inc /de/ CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$3,699,168 28th percentile higher than 28% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Valhi Inc /de/ vs. Chemicals & Pharmaceuticals peers

CEO total pay ($3.7M) against pay ratio (48:1) for Valhi Inc /de/ (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both2820634.87652567.612484500.517316433.422148366.341.6:143.6:145.5:147.4:149.4:1CEO total payPay ratio (CEO : median worker)Valhi Inc /de/, CEO total pay: 3699168 · Pay ratio (CEO : median worker): 48:1Valhi Inc /de/Alnylam Pharmaceuticals, Inc., CEO total pay: 14984640 · Pay ratio (CEO : median worker): 48:1Alnylam Pharmaceuticals, Inc.Vaxcyte, Inc., CEO total pay: 14585904 · Pay ratio (CEO : median worker): 48:1Vaxcyte, Inc.Madrigal Pharmaceuticals, Inc., CEO total pay: 18959941 · Pay ratio (CEO : median worker): 47:1Madrigal Pharmaceuticals, Inc.Adaptive Biotechnologies Corp, CEO total pay: 9147140 · Pay ratio (CEO : median worker): 47:1Adaptive Biotechnologies CorpViking Therapeutics, Inc., CEO total pay: 21269833 · Pay ratio (CEO : median worker): 49:1Viking Therapeutics, Inc.
Valhi Inc /de/ vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Valhi Inc /de/'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Valhi Inc /de/

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
48:1
FY2025
vs prior FY
+21:1
from FY2024 27:1
CEO $ YoY
+46%
$3.7M latest
Filings shown
5
FY2021–2025
Valhi Inc /de/ CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $129K - $129,210 58:1 -
2022 $9.0M +6828% $79,221 113:1 +55:1
2023 $2.1M -76% $91,653 23:1 -90:1
2024 $2.5M +20% $93,695 27:1 +4:1
2025 $3.7M +46% $77,066 48:1 +21:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 59255, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
48:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$3.7M
Companies in Industry
168
vs. Industry Median
Above
#74 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Valhi Inc /de/: MODEST · MID$ pay ratio

Valhi Inc /de/'s FY2025 CEO total $3.7M ranks #1028 of 1,423 complete filings (lower third by dollars). the CEO earned 48× the median employee ($77,066) in FY2025.

Median employee $77,066 (HIGH-MED); MODEST · MID$ stamps put about 48 median-wage years per CEO year.

CEO Total Pay

$3.7M

FY2025 Summary Compensation, below median

Pay Ratio

48:1

Below typical

Valhi Inc /de/ in the lower-dollar third

Valhi Inc /de/'s FY2025 CEO total $3.7M ranks #1028 of 1,423 complete filings (lower third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Valhi Inc /de/'s $3.7M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1028 and ratio rank #989 split - treat 48:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$3.7M
Median Employee Pay
$77,066
Pay Ratio
48:1
Filing Date
2026-04-01

Company Info

Ticker
VHI
CIK
59255
Industry
Chemicals & Pharmaceuticals
SIC Code
2810
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 59255, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Valhi Inc /de/'s FY2025 CEO total $3.7M ranks #1028 of 1,423 complete filings (lower third by dollars).

Read with Valhi Inc /de/

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · HIGH-MED.

Krispy Kreme, Inc. · MID$

ABS(ceo_total_comp) peer at $3.7M (Δ $129 heavier vs Valhi Inc /de/); MID · LOW-MED vs this page's MODEST · MID$ · HIGH-MED.
Glacier Bancorp, Inc. · MID$

ABS(ceo_total_comp) peer at $3.7M (Δ $6K lighter vs Valhi Inc /de/); MODEST · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Quaker Chemical Corp · MID$

ABS(ceo_total_comp) peer at $3.7M (Δ $9K heavier vs Valhi Inc /de/); MODEST · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Ufp Industries Inc · MID$

ABS(ceo_total_comp) peer at $3.7M (Δ $17K lighter vs Valhi Inc /de/); MODEST · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Alnylam Pharmaceuticals, Inc. (SIC 28 pole)

Alnylam Pharmaceuticals, Inc. stamps MODEST · HEAVY nearest in-SIC by ABS(pay_ratio) to Valhi Inc /de/'s MODEST filing.
National dual ranks · #1028/#989

Valhi Inc /de/'s FY2025 package sits #1028 by CEO dollars and #989 by ratio under MID$ · MODEST.
Ratio primer · MODEST

Valhi Inc /de/'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Valhi Inc /de/ (CIK 59255), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.